Buffered L-arginine as treatment of cystic fibrosis: state of the evidence.
D000293:Adolescent; D000336:Aerosols; D001120:Arginine / Q000008:administration & dosage / Q000627:therapeutic use*; D002021:Buffers; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D050356:Lipid Metabolism; D011247:Pregnancy; D013183:Sputum / Q000382:microbiology; D013329:Structure-Activity Relationship
D000336:Aerosols; D002021:Buffers; D001120:Arginine